Achalasia is characterized by loss of esophageal peristalsis and impaired lower esophageal sphincter (LES) relaxation. Progressive loss of nitrergic inhibitory innervation in the esophagus likely plays a major role in the progression of achalasia (1) . This hypothesis is supported by histological studies in patients diagnosed with achalasia, in whom there is a decrease of neurons containing nitric oxide synthase and interstitial cells of Cajal, a unit that likely modulates nitrergic nerve response (2, 3) . Given that the normal physiology of esophageal peristalsis and LES relaxation is dependent on nitrergic innervation (4), it has been hypothesized that achalasia naturally progresses from spastic type III, to pan-pressurization seen in type II, and finally, to loss of esophageal pressurization in advanced type I achalasia (5). To date, there is no data supporting the hypothesis of disease progression between achalasia subtypes. Gastroenterology, 2018, 1(1), 2-3 doi: 10.1093/jcag/gwy002 Image of the Month Advance Access publication 19 March 2018
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We report a case of a previously healthy 60-year-old male who presented with dysphagia and was subsequently diagnosed with type III achalasia by high-resolution esophageal manometry study (EMS) ( Figure 1A) . Following the initial diagnosis, he underwent two pneumatic dilatations without any significant clinical improvement of his dysphagia. Two years later, a repeat EMS demonstrated type II achalasia ( Figure 1B) . This is the first longitudinal clinical case that demonstrates the progression from type III to type II achalasia. It not only strengthens our current understanding of the natural history of achalasia but also supports the hypothesis of the loss of nitrergic inhibitory innervation in the pathogenesis of achalasia.
